Colitis  >>  ASP3291  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ASP3291 / Drais
NCT01612039: Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis

Completed
2
112
US, Canada, RoW
ASP3291, Placebo
Telsar Pharma Inc.
Ulcerative Colitis
04/14
04/14

Download Options